In lung squamous cell carcinoma, GATA6 has a binding site in the promoter region of plasminogen activator urokinase (PLAU), and GATA6 inhibits PLAU transcription by binding to PLAU promoter region, down-regulating PLAU expression, thereby inhibiting the cancer-promoting effect of PLAU50. Here, PLAU is linked to cancer.